Source:http://linkedlifedata.com/resource/pubmed/id/20839158
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
7
|
| pubmed:dateCreated |
2010-11-1
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
1439-0795
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
43
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
281
|
| pubmed:meshHeading |
pubmed-meshheading:20839158-Affective Symptoms,
pubmed-meshheading:20839158-Antipsychotic Agents,
pubmed-meshheading:20839158-Benzodiazepines,
pubmed-meshheading:20839158-Humans,
pubmed-meshheading:20839158-Marijuana Smoking,
pubmed-meshheading:20839158-Medication Adherence,
pubmed-meshheading:20839158-Psychotic Disorders,
pubmed-meshheading:20839158-Risperidone
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
Effect of early dysphoric response and cannabis use on discontinuation of olanzapine or risperidone in patients with early psychosis.
|
| pubmed:publicationType |
Letter,
Clinical Trial
|